NEW YORK, June 26, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Lamb Weston Holdings, Inc. (“Lamb Weston” or the “Company”) (NYSE: LW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lamb Weston investors who…
Month: June 2024
NEW YORK, June 26, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Enphase Energy, Inc. (“Enphase” or the “Company”) (NASDAQ: ENPH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Enphase investors who were…
NEW YORK, June 26, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in UnitedHealth Group Inc. (“UnitedHealth” or the “Company”) (NYSE: UNH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UnitedHealth investors who…
NEW YORK, June 26, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Humana Inc. (“Humana” or the “Company”) (NYSE: HUM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Humana investors who were adversely affected by…
NEW YORK, June 26, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Roblox investors who were adversely…
NEW YORK, June 26, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Intel Corporation (“Intel Corporation” or the “Company”) (NASDAQ: INTC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Intel Corporation investors…
NEW YORK, June 26, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Biogen investors who were adversely affected…
LOS ANGELES, June 26, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Norfolk Southern Corporation (“Norfolk Southern” or “the Company”) (NYSE: NSC) for potential breaches of…
LOS ANGELES, June 26, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UiPath Inc. (“UiPath” or “the Company”) (NYSE: PATH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of…
– XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea’s National Health Insurance Service (NHIS) for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM). – The approval of XPOVIO® by the NHIS in South Korea is the fourth national…
